Morgan Stanley Immuno Precise Antibodies Ltd. Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Morgan Stanley holds 12,533 shares of IPA stock, worth $5,263. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,533
Previous 12,533
-0.0%
Holding current value
$5,263
Previous $8,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IPA
# of Institutions
20Shares Held
1.91MCall Options Held
0Put Options Held
0-
Ingalls & Snyder LLC New York, NY1.56MShares$655,7590.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny78.2KShares$32,8440.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$17,3040.0% of portfolio
-
Northern Trust Corp Chicago, IL41.1KShares$17,2640.0% of portfolio
-
Bank Of Montreal Toronto, A635.3KShares$14,8280.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $10.4M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...